newsfilter
← Latest News
PR Newswire·

Cumberland Pharmaceuticals Announces ASSIST-SSc Trial Top-Line Results

Ifetroban was well tolerated in patients with systemic sclerosis NASHVILLE, Tenn., Oct. 23, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), an innovation-driven biopharmaceutical company advancing